iTeos Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2020 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
iTeos Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
  • iTeos Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -1.05 USD/shares, a 16.7% decline year-over-year.
  • iTeos Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -3.15 USD/shares, a 82.1% decline year-over-year.
  • iTeos Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -3.15 USD/shares, a 216% decline from 2022.
  • iTeos Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was 2.72 USD/shares, a 55.4% decline from 2021.
  • iTeos Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was 6.1 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3 -$6 -216% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 $2.72 -$3 -55.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $6.10 +$8.98 Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 -$3 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.